|

Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)

RECRUITINGSponsored by Ruijin Hospital
Actively Recruiting
SponsorRuijin Hospital
Started2024-08-02
Est. completion2029-03-01
Eligibility
Age14 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06534463

Summary

This study aims to evaluate real-world treatment modalities and their corresponding effectiveness and safety in Chinese patients with marginal zone lymphoma, while also exploratively analyzing patient characteristics and health-related quality of life.

Eligibility

Age: 14 Years+Healthy volunteers accepted
Inclusion Criteria:

* Be diagnosed as MZL
* Meet the treatment indications for MZL

Exclusion Criteria:

* Any reason that, in the investigator's opinion, makes the participant unsuitable to participate in this study.

Conditions2

CancerMarginal Zone Lymphoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.